ProteoDesign
2012
FOUNDED
PRIVATE
STATUS
Early Stage VC
LATEST DEAL TYPE
$2.01M
LATEST DEAL AMOUNT
5
INVESTORS
Description
Developer of new generation of protein therapeutics designed to treat cancer. The company's new generation of protein therapeutics uses proprietary conjugation technologies that helps in the development and production of a superior class of bio-therapeutics, including antibody-drug conjugates, overcoming limitations of the currently used methods, enabling biotech companies to develop better biological drugs and to improve patients' quality of life.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
- Parc Científic de Barcelona (PCB)
- Baldiri Reixac, 10-12
- 08028 Barcelona
- Spain
+34 934 00 00 00
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore ProteoDesign’s full profile, request a free trial.
ProteoDesign Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC | 12-Dec-2017 | $2.01M | 00.000 | Completed | Generating Revenue | |
| 3. Grant | 28-Nov-2015 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 20-Apr-2015 | Completed | Generating Revenue | |||
| 1. Seed Round | 13-Jan-2014 | Completed | Generating Revenue |
ProteoDesign Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| ACC1O | Government | 000 0000 | 000000 0 | |||
| Empresa Nacional de Innovación | Other | Minority | 000 0000 | 000000 0 | ||
| European Union | Government | 000 0000 | 000000 0 | |||
| Spanish Ministry of Foreign Affairs and Cooperation | Government | 000 0000 | 000000 0 | |||
| Caixa Capital Risc | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |
ProteoDesign Executive Team (4)
ProteoDesign Board Members (5)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Alex Casta Ruiz Ph.D | ProteoDesign | Board Member | 000 0000 | |
| Jose Antonio Mesa Cejudo | ProteoDesign | Board Member | 000 0000 | |
| Marc Litchfield | ProteoDesign | Co-Founder & Board Member | 000 0000 | |
| Thomas Muir Ph.D | Self | Co-Founder, Scientific Advisor & Board Member | 000 0000 | |
| William Middlekauff | ProteoDesign | Board Member | 000 0000 |